๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Introduction of wild-type p53 gene downregulates the expression of H-ras gene and suppresses the growth of bladder cancer cells

โœ Scribed by Li, M. ;Gu, F. L. ;Li, W. B. ;Song, Y. S. ;Zhou, A. R. ;Guo, Y. L.


Publisher
Springer
Year
1995
Tongue
English
Weight
460 KB
Volume
23
Category
Article
ISSN
0300-5623

No coin nor oath required. For personal study only.

โœฆ Synopsis


Retroviral vectors were used to introduce the wild-type p53 gene into human bladder cancer cell lines BIU-87 and EJ, which express endogenous wt-p53 gene and have a mutation in H-ras gene. The expression of the exogenous wt-p53 gene in cells suppresses the growth of the bladder cancer cells in standard culture and in soft agar and blocks the cell cycle progression in G1. The BIU-87 and EJ cells developed tumors with average volumes of 6.53 cm3 and 6.61 cm3 in nude mice in 9 weeks after inoculation, while the cells transduced with wt-p53 gene failed to form tumors. The expression of H-ras gene in bladder cancer cells was reduced at mRNA level. These results suggest that the overexpression of the wt-p53 gene suppresses the expression of mutant H-ras gene and inhibits the tumor cell growth in vivo and in vitro.


๐Ÿ“œ SIMILAR VOLUMES


Mutations and expression of the p53 gene
โœ Makoto Asamoto; Angela M. Mann; Timothy L. Macatee; Samuel M. Cohen ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 737 KB

## Abstract Abnormalities of the __p53__ gene are frequently observed in human tumors, including urinary bladder carcinoma, suggesting that __p53__ plays an important role in human carcinogenesis. However, its role in rat bladder carcinogenesis is unclear. We investigated __p53__ gene mutations and

Tissue-specific growth suppression and c
โœ G W Xu; Z T Sun; K Forrester; X W Wang; J Coursen; C C Harris ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 646 KB

HCC patients are generally resistant to chemotherapy, Selective expression of cytotoxic gene products in tuwhich, in some cases, may be the result of a loss of function mor cells is one of the goals of gene therapy for treating mutation in the p53 gene. cancer. We are developing such a strategy for

Dependence of induction of osteocalcin g
โœ Nalini Chandar; Phil Campbell; Josef Novak; Martin Smith; Martin Smith ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 704 KB

## Abstract The __p53__ gene undergoes rearrangement in a high percentage of osteosarcomas, resulting in loss of its expression. A __p53__โ€null murine osteosarcoma cell line F6 was transfected with either a wildโ€type or a mutant __p53__ gene. Stably transfected cell lines were obtained, and their d

Decreased cytotoxic effects of doxorubic
โœ Faina Vikhanskaya; Maurizio D'Incalcimassimo Broggini ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 936 KB

The cytotoxicity of Doxorubicin and cis-dichloro-diammineplatinum (DDP) was evaluated in clones, obtained from a human ovarian cancer cell line transfected with a ternperaturesensitive p53 mutant, which express mutant p53 at 37ยฐC and wild-type-like p53 at 32ยฐC. DDP was equally active in cells not ex